← Leaderboards
Megan A O'Connor
University Of Washington
$3,426,998
Attributed
$3,426,998
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,426,998 · 3
By mechanism
R01$2,375,036 · 1
R21$706,000 · 1
K01$345,962 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Caleb Stokes$974,870
- Jared Baeten$17,463,749
- Nelly Rwamba Mugo$5,256,918
- Mehul Shamal Suthar$8,747,894
- Stephen J. Polyak$9,333,019
Others in their field
Other Emerging Leaders on “Immunocompromised Host”
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$16,660,001
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$12,149,398
- Thomas Dick · Rbhs-New Jersey Medical School$8,498,822
- Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst$5,148,261
- Christopher M Jewell · Baltimore Va Medical Center$4,979,448
- Michael Daniel Keller · Children'S Research Institute$4,910,377
Research focus
Immunocompromised HostImmune ResponseHiv InfectionsFrequenciesPersonsCellsMacaca NemestrinaViralAnimalsNonhuman PrimateImmuneAcuteDisease ProgressionMonocytePathogenesisInflammatoryCo-InfectionInsightInflammationViral Load ResultHospitalizationImmune ActivationAutomobile DrivingExhaustion
Grant awards (8)
Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection$773,874
R01 · FY2025 · HL · contact PI
Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection$785,351
R01 · FY2024 · HL · contact PI
SARS-CoV-2 vaccine durability during SIV infection$353,000
R21 · FY2024 · AI · contact PI
Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection$815,811
R01 · FY2023 · HL · contact PI
SARS-CoV-2 vaccine durability during SIV infection$353,000
R21 · FY2023 · AI · contact PI
Evaluating risks of ZIKV co-infection in SIV-infected macaques$67,508
K01 · FY2022 · MH · contact PI
Evaluating risks of ZIKV co-infection in SIV-infected macaques$139,227
K01 · FY2021 · MH · contact PI
Evaluating risks of ZIKV co-infection in SIV-infected macaques$139,227
K01 · FY2020 · MH · contact PI